Carolina Pinto Ricardo, Principal Analytical Development Scientist, CMC at Purespring, will be in London from 20-22 May to present at the 6th Annual #GeneTherapy Analytical Development Summit Europe. For more: genetherapy-analytical-europe.com #KidneyDisease #Biotech #Innovation

Professor Moin Saleem, our Co-Founder and Chief Scientific Advisor, is presenting at the 62nd @ERAKidney Congress on 5 June. If you are also attending, stop by Hall E1 at 9:15CEST to learn more. For the full #ERA25 agenda: era-online.org/events/vienna-… #KidneyDisease #Biotech

Later today, Mark Bell, Principal Bioprocessing Scientist, will present at #EGeneCell 2025, providing insights into how scalable #manufacturing and end-to-end process integration can support the #ClinicalDevelopment process through to commercial viability. #Innovation #Biotech

The Purespring team is headed to the 15th International #PodocyteConference2025, which kicks off in Hamburg on 10 June. Be sure to stop by our Co-Founder and Chief Scientific Advisor, Professor Moin Saleem’s, presentation to learn more about our precision #nephrology approach.

Professor Moin Saleem, Purespring’s Co-founder & Chief Scientific Advisor, will be speaking at #UKKW25, hosted by The UK Kidney Association. Don’t miss the chance to learn about the potential of our #pipeline to transform #KidneyDisease treatment via precision #podocyte-targeted delivery.

Our CEO, Haseeb Ahmad, and CMO, Fredrik Erlandsson, will be in Boston to engage in discussions on the future of #biotech at the Biotechnology Innovation Organization (BIO) International Convention. If you are interested in setting up a meeting, please reach out via the BIO Partnering platform. #BIO2025

We are thrilled to have been identified by Labiotech.eu as one of the six #KidneyDisease companies you should know about in 2025, highlighting our commitment to transforming the treatment paradigm via our precision #nephrology approach: labiotech.eu/best-biotech/k… #Biotech

🔊Listen now to a special episode of @LaBiotech_eu's 'Beyond Biotech' podcast, in which our CEO, Haseeb Ahmad, speaks on his experience at the 2025 Biotechnology Innovation Organization International Convention: podcast.labiotech.eu/1995493/episod… #BIO2025 #KidneyDisease #Biotech

Throughout the month of June, Purespring has been celebrating #PrideMonth. We believe that scientific excellence and #innovation rely on #diversity, and, guided by our core values, we aim to create an inclusive environment where everyone is free to be themselves. #KidneyDisease

We are excited to announce we have received FDA #IND clearance for PS-002, our lead programme initially targeting IgAN disease. This will enable the initiation of a Phase I/II #ClinicalTrial later this year. For more purespringtx.com/purespring-the… #KidneyDisease

This week, Sandra Currie, CEO of Kidney Research UK, and her team shared an inspiring talk about their work funding research, raising awareness & improving treatments for #kidneydisease. We’re proud to have raised £1,400 at the #LondonBridgesWalk to support this vital cause.

We are thrilled to announce that we have received CTA approval from the UK MHRA, NHS HRA and REC for PS-002, our lead programme initially targeting #IgAN. This will enable initiation of a Phase I/II #ClinicalTrial in Q4 2025. For more purespringtx.com/purespring-the…

Our CEO, Haseeb Ahmad, and CFO, Sachin Kelkar, will be in New York City from 8-10 Sept. to attend the Morgan Stanley Global #Healthcare Conference. If you are also attending and want to learn more about our precision nephrology approach, please reach out to arrange a meeting.

On 17 September, Purespring’s management team will be participating in 1:1 meetings at the Bank of America Healthcare Trailblazers Private Company Conference in Boston. Please reach out if you wish to learn more about Purespring’s innovative #pipeline: purespringtx.com/purespring-the…

On 1 October, Fredrik Erlandsson, CMO, will be presenting ‘Advancing #PrecisionNephrology & #Podocyte Targeted Therapies' at the 5th Annual Rare & Genetic #KidneyDisease Drug Development Summit from 12:00-12:30EDT. Be sure to stop by if you are also attending. #Biotech #Kidney

Our CFO, Sachin Kelkar, and CSO, Alice Brown, will be in New York City on 21 October to present at Chardan’s 9th Annual #GeneticMedicinesConference. If you would like to learn more, reach out to set up a meeting: purespringtx.com/purespring-the… #PrecisionNephrology #CGMC2025

We are thrilled to #welcome Dr Nick Deakin, who joins Purespring as VP, Head of #BusinessDevelopment and Strategy. With an extensive background in defining and executing on strategic opportunities, his expertise will be critical as we enter our next phase of growth. #Leadership

Our Co-founder & Chief Scientific Advisor, Moin Saleem, and CMO, Fredrik Erlandsson, will be presenting at the @ASN #KidneyWeek2025 in Houston, TX, from November 5-9! To learn more: purespringtx.com/purespring-to-… #GeneticMedicines #KidneyDiseases #Biotech

The Purespring management team will be in London next week for the Jefferies London #HealthcareConference. If you will also be there and would like to discuss our targeted, first-in-class genetic therapies to preserve kidney function, please get in touch. #KidneyDiseases

The Purespring team have left Houston, feeling energised after an engaging #ASN2025! Thank you to ASN #KidneyWeek2025 organisers for an exceptional program, and we are already looking forward to next year! #GeneticMedicines #KidneyDiseases #Biotech